161 related articles for article (PubMed ID: 9171836)
21. Mapping of a second locus for familial hemiplegic migraine to 1q21-q23 and evidence of further heterogeneity.
Ducros A; Joutel A; Vahedi K; Cecillon M; Ferreira A; Bernard E; Verier A; Echenne B; Lopez de Munain A; Bousser MG; Tournier-Lasserve E
Ann Neurol; 1997 Dec; 42(6):885-90. PubMed ID: 9403481
[TBL] [Abstract][Full Text] [Related]
22. Phenotypic and genetic heterogeneity of familial hyperkalaemic hypertension (Gordon syndrome).
Achard JM; Disse-Nicodeme S; Fiquet-Kempf B; Jeunemaitre X
Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1048-52. PubMed ID: 11903313
[TBL] [Abstract][Full Text] [Related]
23. Significant linkage to migraine with aura on chromosome 11q24.
Cader ZM; Noble-Topham S; Dyment DA; Cherny SS; Brown JD; Rice GP; Ebers GC
Hum Mol Genet; 2003 Oct; 12(19):2511-7. PubMed ID: 12915447
[TBL] [Abstract][Full Text] [Related]
24. Gordon's syndrome, renal tubule, chromosome 17 and essential hypertension: a credible link?
Soubrier F
J Hum Hypertens; 1998 Oct; 12(10):663-4. PubMed ID: 9819011
[No Abstract] [Full Text] [Related]
25. The molecular basis of hypertension.
Toka HR
Turk J Pediatr; 2002; 44(3):183-93. PubMed ID: 12405428
[TBL] [Abstract][Full Text] [Related]
26. Complete and overlapping congenics proving the existence of a quantitative trait locus for blood pressure on Dahl rat chromosome 17.
Grondin M; Eliopoulos V; Lambert R; Deng Y; Ariyarajah A; Moujahidine M; Dutil J; Charron S; Deng AY
Physiol Genomics; 2005 Mar; 21(1):112-6. PubMed ID: 15632271
[TBL] [Abstract][Full Text] [Related]
27. Alleles of the spontaneously hypertensive rat decrease blood pressure at loci on chromosomes 4 and 13.
Kovács P; Voigt B; Klöting I
Biochem Biophys Res Commun; 1997 Sep; 238(2):586-9. PubMed ID: 9299556
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive linkage and linkage heterogeneity analysis of 4344 sibling pairs affected with hypertension from the Family Blood Pressure Program.
Greenwood TA; Libiger O; Kardia S; Hanis C; Morrison AC; Gu CC; Rice T; Miller M; Turner ST; Myers RH; Grove J; Hsiao CF; Weder AB; Schork NJ
Genet Epidemiol; 2007 Apr; 31(3):195-210. PubMed ID: 17266112
[TBL] [Abstract][Full Text] [Related]
29. Hereditary causes of hypertension due to increased sodium transport.
Zhang J
Curr Opin Pediatr; 2024 Apr; 36(2):211-218. PubMed ID: 37909881
[TBL] [Abstract][Full Text] [Related]
30. A case report of pseudohypoaldosteronism type II with a homozygous KLHL3 variant accompanied by hyperthyroidism.
Zhang R; Zhang S; Luo Y; Li M; Wen X; Cai X; Han X; Ji L
BMC Endocr Disord; 2021 May; 21(1):103. PubMed ID: 34022862
[TBL] [Abstract][Full Text] [Related]
31. Familial mesial temporal lobe epilepsy maps to chromosome 4q13.2-q21.3.
Hedera P; Blair MA; Andermann E; Andermann F; D'Agostino D; Taylor KA; Chahine L; Pandolfo M; Bradford Y; Haines JL; Abou-Khalil B
Neurology; 2007 Jun; 68(24):2107-12. PubMed ID: 17377072
[TBL] [Abstract][Full Text] [Related]
32. Pseudohypoaldosteronism type 2 presenting with hypertension and hyperkalaemia due to a novel mutation in the WNK4 gene.
Brooks AM; Owens M; Sayer JA; Salzmann M; Ellard S; Vaidya B
QJM; 2012 Aug; 105(8):791-4. PubMed ID: 21764813
[No Abstract] [Full Text] [Related]
33. Pseudohypoaldosteronism Type II or Gordon Syndrome: A Rare Syndrome of Hyperkalemia and Hypertension With Normal Renal Function.
Manas F; Singh S
Cureus; 2024 Jan; 16(1):e52594. PubMed ID: 38374860
[TBL] [Abstract][Full Text] [Related]
34. Pseudohypoaldosteronism with normal blood pressure.
Shoker A; Morris G; Skomro R; Laxdal V
Clin Nephrol; 1996 Aug; 46(2):105-11. PubMed ID: 8869787
[TBL] [Abstract][Full Text] [Related]
35. Syndrome of hypertension and hyperkalemia with normal GFR (Gordon's syndrome: pseudohypoaldosteronism type II).
Wang XY; Guo JZ; Qian WQ; Kong Y; Dong DC
Chin Med J (Engl); 1993 Dec; 106(12):933-7. PubMed ID: 8143511
[No Abstract] [Full Text] [Related]
36. Hyperkalemic periodic paralysis in Gordon's syndrome: a possible defect in atrial natriuretic peptide function.
Pasman JW; Gabreëls FJ; Semmekrot B; Renier WO; Monnens LA
Ann Neurol; 1989 Sep; 26(3):392-5. PubMed ID: 2529811
[TBL] [Abstract][Full Text] [Related]
37. Salt-Losing Syndrome in a Girl with Type I and II Pseudohypoaldosteronism.
Szmigielska A
Am J Case Rep; 2022 Oct; 23():e937536. PubMed ID: 36303414
[TBL] [Abstract][Full Text] [Related]
38. Increased chloride reabsorption as an inherited renal tubular defect in familial type II pseudohypoaldosteronism.
Take C; Ikeda K; Kurasawa T; Kurokawa K
N Engl J Med; 1991 Feb; 324(7):472-6. PubMed ID: 1988833
[No Abstract] [Full Text] [Related]
39. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene.
Gong H; Tang Z; Yang Y; Sun L; Zhang W; Wang W; Cui B; Ning G
Endocrine; 2008 Jun; 33(3):230-4. PubMed ID: 19016006
[TBL] [Abstract][Full Text] [Related]
40. Pseudohypoaldosteronism types I and II: little more than a name in common.
Casas-Alba D; Vila Cots J; Monfort Carretero L; Martorell Sampol L; Zennaro MC; Jeunemaitre X; Camacho Díaz JA
J Pediatr Endocrinol Metab; 2017 May; 30(5):597-601. PubMed ID: 28593901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
